Ketamine for the treatment of addiction: Evidence and potential mechanisms. (2018)
Attributed to:
Reducing relapse in alcohol dependence with the NMDA receptor antagonist, ketamine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.neuropharm.2018.01.017
PubMed Identifier: 29339294
Publication URI: http://europepmc.org/abstract/MED/29339294
Type: Journal Article/Review
Volume: 142
Parent Publication: Neuropharmacology
ISSN: 0028-3908